Yanal Masannat, MD
Endocrinology, Diabetes & Metabolism · Yuma, AZNPI 1053543009
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in AZ, where the typical reported total is $2,225.
Across 10 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$47
- GSK$30
- Baxter Healthcare$30
- Medtronic$25
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$21
- Tandem Diabetes Care, Inc.$18
- plus $28 from 2 others
What the payments were for
- Food & beverage$198100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2 | $47 |
| GSK | 2 | $30 |
| Baxter Healthcare | 1 | $30 |
| Medtronic | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $11 |
How this compares
$198 in reported general payments places this provider in the 15th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 454 | $746,399 |
| JardianceEmpagliflozin | 377 | $476,544 |
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 15 | $230,046 |
| OzempicSemaglutide | 144 | $187,167 |
| JanuviaSitagliptin Phosphate | 100 | $100,438 |
| FarxigaDapagliflozin Propanediol | 70 | $83,676 |
| Victoza 3-PakLiraglutide | 49 | $62,035 |
| HumatropeSomatropin | 15 | $60,867 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 94 | $53,026 |
| Humalog Kwikpen U-100Insulin Lispro | 78 | $36,904 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 200 | $35,335 |
| Novolog FlexpenInsulin Aspart | 93 | $33,112 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 19 | $27,624 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $27,412 |
| Bydureon BciseExenatide Microspheres | 15 | $25,805 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Yuma
- Manju SchorrYuma$24K
- Muhammad SethiTucson$670K
- Kevin YuenPhoenix$404K
- Amir HarariScottsdale$361K
- Joan BaileyPhoenix$316K
- Kristina BlohmScottsdale$220K
- Karen HerbstTucson$200K
- Laura KnechtCave Creek$142K
- Andrea FerencziScottsdale$132K
- Nora BarsonyTucson$121K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.